...
首页> 外文期刊>Journal of Analytical Methods in Chemistry >Development and Validation of a Chromatography Method Using Tandem UV/Charged Aerosol Detector for Simultaneous Determination of Amlodipine Besylate and Olmesartan Medoxomil: Application to Drug-Excipient Compatibility Study
【24h】

Development and Validation of a Chromatography Method Using Tandem UV/Charged Aerosol Detector for Simultaneous Determination of Amlodipine Besylate and Olmesartan Medoxomil: Application to Drug-Excipient Compatibility Study

机译:使用串联UV /带电气溶胶检测器进行色谱法的开发和验证,同时测定氨氯硝酸盐和奥米氨基甲酸麦莫莫罗马:药物 - 赋形剂相容性研究的应用

获取原文
获取原文并翻译 | 示例
           

摘要

A study was carried out to investigate compatibility of amlodipine besylate and olmesartan medoxomil with a variety of pharmaceutical excipients. Both drugs are antihypertensive agents that can be administered alone, in monotherapy, or in pharmaceutical association. The studies were performed using binary and ternary mixtures, and samples were stored for 3 and 6 months at 40 degrees C under 75% relative humidity and dry conditions. For this study, a method based on high-performance liquid chromatography (HPLC) was developed and validated for the simultaneous determination of amlodipine besylate and olmesartan medoxomil in samples from pharmaceutical preformulation studies using diode array detector (DAD) and charged aerosol detector (CAD). The runtime per sample was 10 min with retention time of 7.926 min and 4.408 min for amlodipine and olmesartan, respectively. The validation was performed according to ICH guidelines. The calibration curve presents linear dynamic range from 12 to 250 mu g mL(-1) for amlodipine and from 25 to 500 mu g mL(-1) for olmesartan with coefficient of determination (R-2 = 0.9908) while repeatability and reproducibility (expressed as relative standard deviation) were lower than 1.0%. The excipients such as corn starch, croscarmellose sodium, magnesium stearate, polyvinyl alcohol, talc, polyvinylpyrrolidone, lactose monohydrate, and polyethylene glycol showed potential incompatibilities after accelerated stability testing.
机译:进行了一种研究,以研究氨氯地平苯磺酸盐和Olmesartan Medoxomil与各种药物赋形剂的相容性。两种药物都是抗高血压药物,可单独给药,单一疗法或药物协会。使用二元和三元混合物进行研究,并在40℃下在75%相对湿度和干燥条件下储存样品3和6个月。对于该研究,开发了一种基于高性能液相色谱(HPLC)的方法,并验证了使用二极管阵列检测器(爸爸)和带电气溶胶检测器(CAD)的药物预制研究中的样品中的氨氯地平苯磺酸盐和Olmesartan常氧诺。(CAD) 。每个样品的运行时间分别为10分钟,保留时间为7.926分钟,分别为氨氯普滨和奥姆森坦的4.408分钟。验证是根据ICH指南进行的。校准曲线呈现为氨氯地平的12至250μg(-1)的线性动态范围,以及用于Olmesartan的25至500μg(-1),其含量测定系数(R-2> = 0.9908),而可重复性和再现性(表达为相对标准偏差)低于1.0%。玉米淀粉,Croscarmellose钠,硬脂酸镁,聚乙烯醇,滑石,聚乙烯吡咯烷酮,乳糖一水合物和聚乙二醇和聚乙二醇等赋形剂在加速稳定性试验后显示出潜在的不相容性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号